PLASMABLASTIC LYMPHOMA
Clinical trials for PLASMABLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PLASMABLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for PLASMABLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo targets hard-to-treat blood cancer in early trial
Disease control Recruiting nowThis study tests whether adding daratumumab to two standard drugs (bortezomib and dexamethasone) can shrink tumors in people with a rare, aggressive blood cancer called plasmablastic lymphoma that has returned or not responded to prior therapy. About 28 adults will receive the co…
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
New hope for HIV patients with aggressive lymphoma: drug combo trial launches
Disease control Recruiting nowThis study tests whether adding the drug pomalidomide to standard chemotherapy (with or without rituximab) is safe and effective for people with HIV who have certain types of non-Hodgkin lymphoma. About 25 adults with high-risk features will receive up to 6 cycles of treatment. T…
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New drug SGR-1505 enters human testing for blood cancers
Disease control Recruiting nowThis early-phase trial tests a new drug, SGR-1505, in about 98 adults with various B-cell blood cancers (like lymphoma or leukemia). The main goals are to check safety, find the best dose, and see how the body handles the drug. Participants must have a confirmed diagnosis and be …
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
Researchers dig into past cases of rare lymphoma to uncover clues
Knowledge-focused Recruiting nowThis study gathers information from the medical records of 200 people diagnosed with plasmablastic lymphoma, a rare blood cancer. Researchers will analyze patient characteristics, treatments, and outcomes to better understand the disease. No new treatments or procedures are given…
Matched conditions: PLASMABLASTIC LYMPHOMA
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC